Cargando…

A prescription survey about combined use of acetylcholinesterase inhibitors and anticholinergic medicines in the dementia outpatient using electronic medication history data from community pharmacies

PURPOSE: We investigated prescriptions regarding the combined use of donepezil hydrochloride (DPZ) and anticholinergics for elderly outpatients in Japan to determine the impact that combination therapy has on decreasing their cognitive functions. METHODS: Using electronic medication records from 142...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurata, Kaori, Taniai, Eitarou, Nishimura, Kanae, Fujita, Kenji, Dobashi, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741018/ https://www.ncbi.nlm.nih.gov/pubmed/29354527 http://dx.doi.org/10.2147/IPRP.S86661

Ejemplares similares

Proportion of Japanese outpatients filling prescriptions for long-term medication regimens
por: Kurata, Kaori, et al.
Publicado: (2019)

Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
por: Hori, Hikaru, et al.
Publicado: (2022)

Potentially inappropriate anticholinergic drug prescriptions for patients with Sjögren's syndrome
por: Valladales-Restrepo, Luis Fernando, et al.
Publicado: (2019)

Anticholinergic drugs and risk of dementia: Time for action?
por: Bell, Brian, et al.
Publicado: (2021)

Analysis of spontaneous inquiries about suspected adverse drug reactions posted by the general public on the electronic Japanese bulletin board “Yahoo! Japan Chiebukuro”
por: Dobashi, Akira, et al.
Publicado: (2016)

Concomitant Cholinesterase Inhibitor and Anticholinergic Drug Use Among Older Adults With Dementia
por: Carter, Elizabeth, et al.
Publicado: (2020)

Prevalence and patterns of the concurrent use of anticholinergics for the motor symptoms of Parkinson’s disease and acetylcholinesterase inhibitors in Parkinson’s disease patients with dementia: a cross-sectional study using Korea National Health Insurance claims data
por: Baik, Deborah, et al.
Publicado: (2022)

Anticholinergic drugs and risk of dementia: case-control study
por: Richardson, Kathryn, et al.
Publicado: (2018)

Anticholinergic drugs and risk of dementia: case-control study
Publicado: (2019)

Association between anticholinergic burden and dementia in UK Biobank
por: Mur, Jure, et al.
Publicado: (2022)

Association between anticholinergic burden and dementia in UK Biobank
por: Mur, Jure, et al.
Publicado: (2021)

Reassessing blood acetylcholinesterase in dementia
por: Han, Pengcheng
Publicado: (2015)

Dose response relationship of cumulative anticholinergic exposure with incident dementia: validation study of Korean anticholinergic burden scale
por: Suh, Yewon, et al.
Publicado: (2020)

Use of Medicines with Anticholinergic and Sedative Effect Before and After Initiation of Anti-Dementia Medications
por: Gadzhanova, Svetla, et al.
Publicado: (2015)

Anticholinergic medicines use among older adults before and after initiating dementia medicines
por: Narayan, Sujita W., et al.
Publicado: (2019)

Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study
por: Grossi, Carlota M., et al.
Publicado: (2019)

Prescription of Anticholinergics in Tardive Syndromes: A “Dual Center” Survey among Psychiatrists
por: Cutino, Anna, et al.
Publicado: (2020)

Risk Indicators Improve the Prescription Quality of Drugs with Anticholinergic Properties in Nursing Homes
por: Sanchez, Stéphane, et al.
Publicado: (2021)

Health Outcomes in Patients Using No-Prescription Online Pharmacies to Purchase Prescription Drugs
por: Cicero, Theodore J, et al.
Publicado: (2012)

Exploring Concomitant Acetylcholinesterase Inhibitor and Overactive Bladder Anticholinergic Use and Risk of Hospitalization in Medicare and Dual-Eligible Medicare–Medicaid Populations in a Historic Database
por: Watanabe, Jonathan H., et al.
Publicado: (2023)

Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications
por: Soiza, Roy L., et al.
Publicado: (2021)

Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta‐analysis
por: Dmochowski, Roger R., et al.
Publicado: (2020)

The Impact of Anticholinergic Use for Overactive Bladder on Cognitive Changes in Adults with Normal Cognition, Mild Cognitive Impairment, or Dementia
por: Welk, Blayne, et al.
Publicado: (2022)

Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study
por: Coupland, Carol A. C., et al.
Publicado: (2019)

Anticholinergic exposure and its association with dementia/Alzheimer's disease and mortality in older adults
por: Poonawalla, Insiya B., et al.
Publicado: (2023)

Use of Drugs With Risk of Heart Rate-Related Problems is Common in Norwegian Dementia Patients Treated With Acetylcholinesterase Inhibitors: A Prevalence Study Based on the Norwegian Prescription Database
por: Efjestad, Anne Sverdrup, et al.
Publicado: (2022)

Anticholinergic discontinuation and cognitive functions in patients with schizophrenia: a pharmacist–physician collaboration in the outpatient department
por: Sathienluckana, Thanompong, et al.
Publicado: (2018)

Anticholinergic Medication Use, Dopaminergic Genotype, and Recurrent Falls
por: Rosso, Andrea, et al.
Publicado: (2020)

Evaluating the Effectiveness of the Computer-Based Education Platform, Pharmacy5in5, on Pharmacists’ Knowledge of Anticholinergic Toxicity Using a Randomized Controlled Trial
por: Hussein, Rand, et al.
Publicado: (2022)

Practical Pharmacy—Incompatibility and Prescription Writing
Publicado: (1939)

Electronic Prescription Errors in an Ambulatory Pharmacy
por: Molitor, Richard, et al.
Publicado: (2011)

Prevalence of Unclaimed Prescriptions at Military Pharmacies
por: Esposito, Dominick, et al.
Publicado: (2008)

Association between different anticholinergic drugs and subsequent dementia risk in patients with diabetes mellitus
por: Yang, Yu-Wan, et al.
Publicado: (2017)

Editorial Comment: Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control
por: Averbeck, Marcio Augusto
Publicado: (2020)

Patterns of outpatient prescription drug use among Pennsylvania elderly
por: Stuart, Bruce, et al.
Publicado: (1991)

Association between acetylcholinesterase inhibitors and risk of stroke in patients with dementia
por: Lin, Yi-Ting, et al.
Publicado: (2016)

Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review
por: Pozzi, Federico Emanuele, et al.
Publicado: (2022)

Improving quantification of anticholinergic burden using the Anticholinergic Effect on Cognition Scale – a healthcare improvement study in a geriatric ward setting
por: Balasundaram, Bharathi, et al.
Publicado: (2022)

Impact of programs to reduce antipsychotic and anticholinergic use in nursing homes
por: Carnahan, Ryan M., et al.
Publicado: (2017)

Anticholinergic Burden and Most Common Anticholinergic-acting Medicines in Older General Practice Patients
por: Gorup, Eva, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ppv85t8buku4lec0ij3qvsjl3i